ARF5 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	27 studies	36% ± 14%	Explore
CD8-positive, alpha-beta T cell	26 studies	38% ± 17%	Explore
conventional dendritic cell	24 studies	47% ± 23%	Explore
CD4-positive, alpha-beta T cell	24 studies	36% ± 15%	Explore
classical monocyte	23 studies	44% ± 17%	Explore
macrophage	21 studies	31% ± 12%	Explore
B cell	20 studies	31% ± 9%	Explore
non-classical monocyte	19 studies	50% ± 17%	Explore
fibroblast	19 studies	34% ± 16%	Explore
regulatory T cell	19 studies	43% ± 12%	Explore
T cell	18 studies	33% ± 12%	Explore
endothelial cell	17 studies	33% ± 14%	Explore
mature NK T cell	16 studies	33% ± 12%	Explore
plasmacytoid dendritic cell	16 studies	42% ± 16%	Explore
memory B cell	15 studies	30% ± 8%	Explore
pericyte	15 studies	35% ± 17%	Explore
smooth muscle cell	14 studies	35% ± 17%	Explore
CD16-negative, CD56-bright natural killer cell, human	13 studies	36% ± 12%	Explore
epithelial cell	13 studies	43% ± 24%	Explore
monocyte	13 studies	36% ± 14%	Explore
gamma-delta T cell	13 studies	36% ± 10%	Explore
CD16-positive, CD56-dim natural killer cell, human	12 studies	42% ± 11%	Explore
myofibroblast cell	12 studies	40% ± 18%	Explore
naive B cell	12 studies	28% ± 6%	Explore
dendritic cell	11 studies	65% ± 19%	Explore
connective tissue cell	11 studies	44% ± 16%	Explore
endothelial cell of lymphatic vessel	11 studies	39% ± 17%	Explore
ciliated cell	10 studies	45% ± 21%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	10 studies	30% ± 6%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	10 studies	37% ± 10%	Explore
capillary endothelial cell	10 studies	29% ± 20%	Explore
CD4-positive, alpha-beta memory T cell	9 studies	42% ± 17%	Explore
CD8-positive, alpha-beta memory T cell	9 studies	41% ± 18%	Explore
basal cell	9 studies	51% ± 23%	Explore
endothelial cell of artery	9 studies	32% ± 19%	Explore
vein endothelial cell	9 studies	32% ± 18%	Explore
mucosal invariant T cell	9 studies	39% ± 6%	Explore
plasmablast	8 studies	39% ± 21%	Explore
secretory cell	8 studies	38% ± 19%	Explore
platelet	8 studies	25% ± 9%	Explore
abnormal cell	8 studies	38% ± 19%	Explore
club cell	7 studies	36% ± 18%	Explore
effector memory CD8-positive, alpha-beta T cell	7 studies	37% ± 11%	Explore
T follicular helper cell	7 studies	32% ± 12%	Explore
innate lymphoid cell	6 studies	28% ± 12%	Explore
hematopoietic stem cell	6 studies	40% ± 12%	Explore
precursor B cell	6 studies	34% ± 11%	Explore
endothelial cell of vascular tree	6 studies	27% ± 12%	Explore
myeloid cell	6 studies	39% ± 9%	Explore
type I pneumocyte	6 studies	41% ± 22%	Explore
exhausted T cell	5 studies	54% ± 10%	Explore
respiratory goblet cell	5 studies	39% ± 24%	Explore
mesothelial cell	5 studies	58% ± 26%	Explore
type II pneumocyte	5 studies	39% ± 21%	Explore
effector CD8-positive, alpha-beta T cell	5 studies	52% ± 12%	Explore
intermediate monocyte	5 studies	59% ± 15%	Explore
hematopoietic precursor cell	4 studies	39% ± 10%	Explore
plasma cell	4 studies	37% ± 10%	Explore
pancreatic A cell	4 studies	38% ± 15%	Explore
mononuclear phagocyte	4 studies	32% ± 11%	Explore
kidney loop of Henle epithelial cell	4 studies	31% ± 12%	Explore
progenitor cell	4 studies	41% ± 21%	Explore
kidney distal convoluted tubule epithelial cell	4 studies	34% ± 11%	Explore
enteroendocrine cell	4 studies	43% ± 20%	Explore
goblet cell	4 studies	26% ± 12%	Explore
leukocyte	4 studies	20% ± 1%	Explore
pro-B cell	4 studies	37% ± 10%	Explore
neuron	4 studies	57% ± 22%	Explore
effector CD4-positive, alpha-beta T cell	4 studies	64% ± 11%	Explore
glutamatergic neuron	4 studies	32% ± 22%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	52% ± 14%	Explore
mast cell	4 studies	21% ± 4%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	4 studies	35% ± 8%	Explore
erythrocyte	4 studies	30% ± 12%	Explore
CD4-positive, alpha-beta cytotoxic T cell	3 studies	48% ± 23%	Explore
precursor cell	3 studies	58% ± 15%	Explore
type B pancreatic cell	3 studies	48% ± 12%	Explore
renal alpha-intercalated cell	3 studies	33% ± 7%	Explore
intestinal crypt stem cell	3 studies	20% ± 3%	Explore
neural crest cell	3 studies	28% ± 5%	Explore
lymphocyte	3 studies	37% ± 15%	Explore
megakaryocyte	3 studies	33% ± 10%	Explore
immature B cell	3 studies	37% ± 5%	Explore
serous secreting cell	3 studies	23% ± 10%	Explore
germinal center B cell	3 studies	38% ± 13%	Explore
myoepithelial cell	3 studies	41% ± 17%	Explore
oligodendrocyte precursor cell	3 studies	32% ± 9%	Explore
group 3 innate lymphoid cell	3 studies	37% ± 8%	Explore
transit amplifying cell	3 studies	17% ± 2%	Explore
T-helper 1 cell	3 studies	46% ± 18%	Explore
T-helper 17 cell	3 studies	37% ± 22%	Explore
double negative thymocyte	3 studies	45% ± 3%	Explore
luminal hormone-sensing cell of mammary gland	3 studies	35% ± 14%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	16 studies	39% ± 9%	Explore
lung	14 studies	35% ± 20%	Explore
kidney	7 studies	28% ± 13%	Explore
intestine	5 studies	32% ± 13%	Explore
lymph node	5 studies	34% ± 16%	Explore
pancreas	4 studies	38% ± 15%	Explore
brain	4 studies	33% ± 18%	Explore
uterus	3 studies	32% ± 14%	Explore
breast	3 studies	25% ± 9%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
liver	100%	2707.33	226 / 226	100%	112.81	406 / 406
ovary	100%	3184.12	180 / 180	100%	213.74	430 / 430
pancreas	100%	3566.60	328 / 328	100%	169.09	178 / 178
skin	100%	6238.73	1809 / 1809	100%	175.78	472 / 472
uterus	100%	4337.13	170 / 170	100%	201.56	459 / 459
thymus	100%	3712.40	653 / 653	100%	151.74	604 / 605
brain	100%	4791.56	2636 / 2642	100%	181.43	705 / 705
esophagus	100%	5021.79	1445 / 1445	99%	100.78	182 / 183
intestine	100%	3942.67	966 / 966	99%	199.71	524 / 527
kidney	100%	4095.66	89 / 89	99%	143.03	895 / 901
stomach	100%	3539.15	359 / 359	99%	158.49	284 / 286
prostate	100%	4050.16	245 / 245	99%	203.29	498 / 502
breast	100%	4175.94	459 / 459	99%	192.38	1105 / 1118
adrenal gland	100%	3330.24	258 / 258	99%	141.01	227 / 230
lung	100%	3885.96	576 / 578	99%	173.08	1143 / 1155
bladder	100%	3587.71	21 / 21	99%	214.51	497 / 504
eye	0%	0	0 / 0	100%	132.04	80 / 80
lymph node	0%	0	0 / 0	100%	195.52	29 / 29
spleen	100%	4301.06	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	169.14	45 / 45
ureter	0%	0	0 / 0	100%	198.83	1 / 1
adipose	100%	3918.69	1203 / 1204	0%	0	0 / 0
blood vessel	100%	3837.14	1333 / 1335	0%	0	0 / 0
muscle	99%	2931.22	798 / 803	0%	0	0 / 0
peripheral blood	99%	4614.10	923 / 929	0%	0	0 / 0
heart	98%	2478.80	847 / 861	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0016192	Biological process	vesicle-mediated transport
GO_0006886	Biological process	intracellular protein transport
GO_0006890	Biological process	retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum
GO_0070062	Cellular component	extracellular exosome
GO_0005794	Cellular component	Golgi apparatus
GO_0005886	Cellular component	plasma membrane
GO_0048471	Cellular component	perinuclear region of cytoplasm
GO_0005737	Cellular component	cytoplasm
GO_0005525	Molecular function	GTP binding
GO_0005515	Molecular function	protein binding
GO_0003924	Molecular function	GTPase activity

IV. Literature review

[source]

Gene name	ARF5
Protein name	ADP-ribosylation factor ADP ribosylation factor 5 ADP-ribosylation factor 5
Synonyms	tcag7.6 hCG_32325
Description	FUNCTION: GTP-binding protein involved in protein trafficking; may modulate vesicle budding and uncoating within the Golgi apparatus. .; FUNCTION: (Microbial infection) Functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase. . FUNCTION: GTP-binding protein involved in protein trafficking; modulates vesicle budding and uncoating within the Golgi apparatus. .
Accessions	ENST00000000233.10 P84085 C9J1Z8 ENST00000415666.1 A4D0Z3

ARF5 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review